Fibrodysplasia Ossificans Progressiva Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Faces of Fibrodysplasia Ossificans Progressiva: Lessons from a Clinical Masquerader
ConclusionsClinical suspicion followed by molecular testing is straightforward for a confirmed diagnosis of FOP. It is not only diagnostic, cost-effective, and saves time but also avoids unnecessary interventions in these patients. (Source: Indian Journal of Pediatrics)
Source: Indian Journal of Pediatrics - September 12, 2023 Category: Pediatrics Source Type: research

Garetosmab in Fibrodysplasia Ossificans Progressiva: Clinical Pharmacology Results From the Phase 2 LUMINA-1 Trial
This article is protected by copyright. All rights reserved.PMID:37694449 | DOI:10.1002/jcph.2344 (Source: The Journal of Clinical Pharmacology)
Source: The Journal of Clinical Pharmacology - September 11, 2023 Category: Drugs & Pharmacology Authors: Yuhuan Wang Jenny-Hoa Nguyen Ruben D de Ruiter Jeanne Mendell Dushyanth Srinivasan John D Davis E Marelise W Eekhoff Source Type: research

Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva
Fibrodysplasia ossificans progressive (FOP) is an ultra-rare genetic disorder that is caused by a mutation in the ACVR1 gene and provokes severe heterotopic ossification. Since flares of the disease are associate... (Source: Pediatric Rheumatology)
Source: Pediatric Rheumatology - August 29, 2023 Category: Rheumatology Authors: Irina P. Nikishina, Svetlana V. Arsenyeva, Valeria G. Matkava, Alia N. Arefieva, Mariya I. Kaleda, Alexandr V. Smirnov, Leonid M. Blank and Mikhail M. Kostik Tags: Research article Source Type: research

The terminal period findings of late-diagnosed fibrodysplasia ossificans progressiva
Ger Med Sci. 2023 Jul 11;21:Doc12. doi: 10.3205/000326. eCollection 2023.ABSTRACTFibrodysplasia ossificans progressiva (FOP) is an autosomal dominant rare disease characterized by foot deformities and concomitant heterotopic ossifications. Theoretically, in the absence of early diagnosis and medication, the patient's outcome will be poor. The patients are usually diagnosed at an early age. Hence, encountering a non-treated and terminal-period patient is rare. Our case was unique because it showed the clinical picture and atypical radiological distribution of a 20-year-old, terminally ill untreated female patient. She had h...
Source: GMS German Medical Science - August 21, 2023 Category: General Medicine Authors: Emrah Do ğan H üseyin Aydoğmuş Cenk Elibol Sinem Aydo ğmuş Source Type: research